drug
caspofungin acetate
Marketedupdated 4mo agoby United Biomedical Inc
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying caspofungin acetate
Patent cliff
source: FDA Orange Bookfirst barrier falls
Dec 21, 2032
~6.3 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (2)
- Dec 21, 2032formulationUS 9636407
- Dec 21, 2032formulationUS 9636407
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 7h ago
Found something off?
comments(0)
5-min edit window · permanent after that